18 F-FDG PET/MR imaging in patients with suspected liver lesions: Value of liver-specific contrast agent Gadobenate dimeglumine.

Julian KirchnerLino M SawickiCornelius DeuschlJohannes GrüneisenKarsten BeiderwellenThomas C LauensteinKen HerrmannMichael ForstingPhilipp HeuschLale Umutlu

Published in: PloS one (2017)

The application of the liver-specific contrast phase in 18F-FDG PET/MRI further increases the diagnostic accuracy and diagnostic confidence for correct assessment of benign and malignant liver lesions.

Keyphrases

pet ct
positron emission tomography
contrast enhanced
pet imaging
computed tomography
magnetic resonance